Out today in @natecoevo.nature.com!
๐ www.nature.com/articles/s41...
We compare the mutational tolerance of enteroviruses A & B across their full proteomes, mapping distinct host interaction strategies ๐ฆ and identifying mutation-resistant regions that could inform antiviral development ๐
23.02.2026 13:42
๐ 14
๐ 10
๐ฌ 0
๐ 0
Un comentario sobre nuestra ultima publicaciรณn.
24.02.2026 10:28
๐ 0
๐ 0
๐ฌ 0
๐ 0
Final version just came out in Nature Ecology and Evolution. www.nature.com/articles/s41...
23.02.2026 11:14
๐ 4
๐ 0
๐ฌ 0
๐ 0
An Evolutionary Story of Agency
๐งช๐งฌ 'An Evolutionary Story of Agency', an #OpenAccess book, exposes the role of "agency" in the history of life. Explores how life has made its way on our planet with forms of agency as diverse as those shown by bacteria, plants or animals. bit.ly/4ahuBmV #evolution @julipereto.bsky.social
30.01.2026 17:30
๐ 8
๐ 3
๐ฌ 0
๐ 0
๐ข Call for a postdoctoral position in virology
๐ Institute of Virology, Medical University of Innsbruck, Austria
๐ 5 years | Full-time
๐
Starting 1 April 2026
๐ Apply: virologie.i-med.ac.at/postdoctoral...
#CapacityStrengthening @geroldlab.bsky.social
30.01.2026 17:11
๐ 3
๐ 4
๐ฌ 0
๐ 0
New positions in CSIC published, some at @i2sysbio.es . Come join our institute. www.ciencia.gob.es/es/Ministeri...
05.01.2026 13:46
๐ 0
๐ 0
๐ฌ 0
๐ 0
A Tetrapodal Tryptophan Derivative with Multiple Exposed Free Carboxylic Acids Blocks Host Cell Entry of Omicron SARS-Cov-2 and Respiratory Syncytial Virus
Omicron sublineages of SARS-CoV-2 have accelerated the spread of the virus and facilitated immune escape. In this work, we demonstrate that compound 2, a potent HIV and enterovirus A71 (EV-A71) entry inhibitor previously discovered in our research group, also displays potent in vitro activity against different SARS-CoV-2 Omicron variants while showing no activity against the ancestral SARS-CoV-2 Wuhan strain. Moreover, its sodium salt (2-Na salt) exhibited in vivo antiviral activity in a murine model of Omicron BA.1. infection. Indeed, biophysical and cryo-EM studies revealed binding of 2-Na salt to the Omicron BA.1 spike (S) protein stabilizing a โclosedโ form in which โผ75% of the S particles have all RBDs down, unlike the usual โopenโ form with one RBD up. Such โclosedโ form decreases S avidity for the cellular receptor ACE2, thus inhibiting viral entry. Computer-assisted modeling studies strongly suggest that 2 can interact with the intersubunit cavity of the S trimer of the Omicron BA.1 subvariant, making use of the multivalency principle. In this context, compound 2 can be considered a pharmacological tool for studying and validating new antiviral strategies against Omicron variants. We also identified 2 as a potent inhibitor of RSV and the Ebola virus. The effectiveness of 2 against a diverse set of viruses of different families supports its use as a promising lead for the development of entry inhibitors against current and future viral infections, representing a meaningful advance in the field.
Another collaborative effort to uncover new broad-spectrum antivirals! This one works for SARS-CoV-2, respiratory syncytial virus, and Ebolavirus (as well as HIV and EVA71 from another work). pubs.acs.org/doi/10.1021/...
18.11.2025 09:20
๐ 2
๐ 1
๐ฌ 0
๐ 1
You know something exciting is happening when three lab members are working together to get it done!
29.10.2025 14:41
๐ 0
๐ 0
๐ฌ 0
๐ 0
ComFuturo Fourth Edition: ComFuturo iAGE Call - FGCSIC
The Fundaciรณn General CSIC (FGCSIC) launches the fourth edition of its ComFuturo programme: ComFuturo iAGE, a postdoctoral initiative co-financed by the Marie Skลodowska-Curie Actions COFUND scheme of...
๐จJOB ALERT
Dr. Buceta at @i2sysbio.es welcome applications for 36-month postdocs on:
๐ Mechanical markers of tissue dysfunction due to ageing โ digital twins & machine learning
Details here: fgcsic.es/convocatoria...
๐ฉ Contact javier.buceta@csic.es to shape your proposal!
@epimechfc.bsky.social
13.10.2025 13:03
๐ 6
๐ 10
๐ฌ 0
๐ 5
Thanks for sharing, Marco. A clever way to get around neutralizing antibody issues for oncolytic virus delivery!
25.09.2025 06:55
๐ 2
๐ 0
๐ฌ 0
๐ 0
i2sysbio - Position
Quedan 2 semanas para postular a un doctorado en nuestro laboratorio (interacciones arbovirus-hospedador).
๐ Tรญtulo universitario (fuera de la UE, >2020) + mรกster relevante requeridos.
๐ Detalles: i2sysbio.es/position/7/.
#PhDposition #Virologรญa #Arbovirus ๐ฆ๐งฌ๐
17.05.2025 05:56
๐ 0
๐ 1
๐ฌ 0
๐ 0
๐ข Exciting news! We will soon open two PhD positions at @i2sysbio.bsky.social @csic.es, in research projects in collaboration with the @bsc-cns.bsky.social. Both are related to tools to simulate biological tissues. Hereโs the description of the open positions. #PhDpositions #PhDOpportunities
๐
06.05.2025 08:46
๐ 10
๐ 10
๐ฌ 1
๐ 2
A recent effort from the enterovirologists in the @rongellerlab.bsky.social. Interested in making or utilizing fluorescent reporter enteroviruses? Take a look. A Fluorescent Reporter Virus Toolkit for Interrogating Enterovirus Biology and Host Interactions www.preprints.org/manuscript/2...
06.05.2025 04:03
๐ 3
๐ 0
๐ฌ 0
๐ 1
4-year PhD fellowship in Virology available in our group @i2sysbio.bsky.social. Eligibility requires having a relevant university degree from outside of the EU obtained after 1/1/2020 and having (or soon to have) a relevant Master degree (preferably from Spain). See i2sysbio.es/position/7/
24.04.2025 12:07
๐ 1
๐ 0
๐ฌ 0
๐ 1
Un excelente resumen de nuestros resultados recientes sobre el descubrimiento de nuevos antivirales para SARS-CoV-2 y el virus sincitial respiratorio.
21.03.2025 09:08
๐ 3
๐ 0
๐ฌ 0
๐ 0
Synthetic heparan sulfate mimics based on chitosan derivatives show broad-spectrum antiviral activity
Communications Biology - Identification of safe and effective broad-spectrum antivirals based on modified chitosan sulfate derivatives.
Our recent collaborative work showing the promising broad-spectrum antiviral activity of chitosan sulfate derivatives against SARS-CoV-2, RSV, and Sindbis virus is finally online. Check it out! Detailed mechanisms and in vivo characterization included! rdcu.be/eb9IQ
04.03.2025 12:03
๐ 5
๐ 1
๐ฌ 0
๐ 2
Yesterday we had the first #ValenciaVirologyMeeting. Great to see we have a solid virology community right here! Thanks Rafa Sanjuan and @SantiagoFElena for helping to chair our discussion on de novo virus design and synthetic viruses and Jesus Rodriguez Diaz for co-organizing.
06.02.2025 11:08
๐ 6
๐ 1
๐ฌ 0
๐ 1
Addgene: Ron Geller Lab Materials
Making recombinant VSV? Our codon-optimized helper plasmids are now available at @Addgene: www.addgene.org/Ron_Geller/. Method details here: www.nature.com/articles/s41...
31.01.2025 08:22
๐ 3
๐ 0
๐ฌ 0
๐ 1
A farewell lunch to Marianoel Pereira from Pasteur Institute of Montevideo in Uruguay who spent a couple of months in our lab learning high-fidelity Illumina sequencing of viruses.
30.11.2024 18:17
๐ 3
๐ 0
๐ฌ 0
๐ 1